LWC Limarys Wellness ConciergeLWCPEPTIDES

LWC

Peptide Catalog

Explore Our Wellness Collection

AOD-9604 vial

Weight Management

AOD-9604

Contact for details

  • •Modified fragment of human growth hormone.
  • •Early research explored effects on fat metabolism.
  • •Human evidence is limited and inconclusive.
Cagrilintide vial

Weight Management

Cagrilintide

5 mg

  • •Long-acting amylin analogue peptide.
  • •Studied alone and in combination with GLP-1 agents.
  • •Not approved for human use outside clinical trials.
Lemon Bottle vial

Weight Management

Lemon Bottle

Contact for details

  • •Cosmetic solution marketed for aesthetic use.
  • •Independent clinical evidence is very limited.
  • •Should only be considered with a licensed professional.
Retatrutide vial

Weight Management

Retatrutide

10 mg · 15 mg · 20 mg

  • •Triple GIP, GLP-1 and glucagon receptor agonist.
  • •Currently being studied in clinical trials.
  • •Long-term safety has not been established.
Tirzepatide vial

Weight Management

Tirzepatide

10 mg · 20 mg · 30 mg

  • •Dual GIP and GLP-1 receptor agonist peptide.
  • •FDA-approved brand products exist and require a prescription.
  • •Compounded or research versions are not FDA-approved.